Sanara MedTech Inc. (SMTI) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sanara MedTech Inc. (SMTI:NASDAQ), powered by AI.

Current Price
$20.81
P/E Ratio
-4.8
Market Cap
179M
Sector
Healthcare
What is the Sanara MedTech Inc. stock price forecast?

Sanara MedTech Inc. is currently trading at $20.81. View real-time AI analysis on Alpha Lenz.

What is Sanara MedTech Inc. insider trading activity?

View the latest insider trading data for Sanara MedTech Inc. on Alpha Lenz.

What is Sanara MedTech Inc.'s P/E ratio?

Sanara MedTech Inc.'s P/E ratio is -4.8.

Sanara MedTech Inc.

NASDAQ · SMTI
$20.81-0.69(-3.21%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Sanara MedTech Inc.'s future dividend policy...
Alpha Chat Insight

Sanara MedTech Inc. trades at a P/E of -4.8 (undervalued) with modest ROE of -165.7%. 3Y revenue CAGR of 31.0% highlights clear growth momentum.

Ask for details

Company Overview

Sanara MedTech Inc. is a medical technology company specializing in developing and commercializing advanced wound care products and technologies. The company's primary focus is on enhancing patient outcomes through innovative solutions that address the complex needs of wound management and skin care. Sanara MedTech offers a comprehensive suite of products, including antimicrobial wound dressings, collagen-based products, and surgical site management solutions, which are designed to improve healing and reduce infection risks in chronic and acute wounds. Operating primarily in the healthcare sector, Sanara MedTech collaborates with healthcare providers, hospitals, and outpatient facilities, providing them with cutting-edge technologies that support efficient patient care. The company's commitment to research and development ensures that it remains at the forefront of innovation in the medical field, addressing some of the significant challenges faced by clinicians today. Sanara MedTech's contributions to the wound care industry underscore its vital role in the market, as it not only aids in advancing medical practices but also promotes improved quality of life for patients worldwide. This has positioned the company as a key player in the healthcare landscape, catering to the increasing demand for effective wound care solutions.

CEOMr. Seth D. Yon
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees141

Company Statistics

FY 2025

Profile

$179.45MMarket Cap
$103.12MRevenue
0.00Shares Out
141Employees

Margins

92.71%Gross
11.78%EBITDA
8.87%Operating
-0.38%Pre-Tax
-36.43%Net

Valuation

-4.78P/E
30.22P/B
1.74EV/Sales
17.38EV/EBITDA
83.95P/FCF

Growth (CAGR)

31.02%Rev 3Yr
45.92%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-46.66%ROA
-165.69%ROE
7.91%ROIC

Financial Health

$16.58MCash & Cash Equivalents
$50.44MNet Debt
1130.13%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sanara MedTech Inc. (ticker: SMTI) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 141 employees. Market cap is $179M.

The current price is $20.81 with a P/E ratio of -4.78x and P/B of 30.22x.

ROE is -165.69% and operating margin is 8.87%. Annual revenue is $103M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sanara MedTech Inc. (SMTI) Stock Forecast 2026 $20.81 — Price, Financials & Analyst Targets | Alpha Lenz